| Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 YK Yeoh, T Zuo, GCY Lui, F Zhang, Q Liu, AYL Li, ACK Chung, ... Gut 70 (4), 698-706, 2021 | 1108 | 2021 |
| HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos (t) ide analogues TCF Yip, GLH Wong, HLY Chan, YK Tse, KLY Lam, GCY Lui, VWS Wong Journal of hepatology 70 (3), 361-370, 2019 | 216 | 2019 |
| Tenofovir is associated with lower risk of hepatocellular carcinoma than entecavir in patients with chronic HBV infection in China TCF Yip, VWS Wong, HLY Chan, YK Tse, GCY Lui, GLH Wong Gastroenterology 158 (1), 215-225. e6, 2020 | 191 | 2020 |
| Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19 TCF Yip, GCY Lui, VWS Wong, VCY Chow, THY Ho, TCM Li, YK Tse, ... Gut 70 (4), 733-742, 2021 | 167 | 2021 |
| Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population TCF Yip, AJ Ma, VWS Wong, YK Tse, HLY Chan, PC Yuen, GLH Wong Alimentary pharmacology & therapeutics 46 (4), 447-456, 2017 | 161 | 2017 |
| Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B YC Hsu, TCF Yip, HJ Ho, VWS Wong, YT Huang, HB El-Serag, TY Lee, ... Journal of hepatology 69 (2), 278-285, 2018 | 148 | 2018 |
| Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance TCF Yip, HLY Chan, VWS Wong, YK Tse, KLY Lam, GLH Wong Journal of hepatology 67 (5), 902-908, 2017 | 140 | 2017 |
| Data-gru: Dual-attention time-aware gated recurrent unit for irregular multivariate time series Q Tan, M Ye, B Yang, S Liu, AJ Ma, TCF Yip, GLH Wong, PC Yuen Proceedings of the AAAI conference on artificial intelligence 34 (01), 930-937, 2020 | 110 | 2020 |
| Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: a propensity score landmark analysis JC Hsiang, GLH Wong, YK Tse, VWS Wong, TCF Yip, HLY Chan Journal of hepatology 63 (5), 1190-1197, 2015 | 108 | 2015 |
| Durability of hepatitis B surface antigen seroclearance in untreated and nucleos (t) ide analogue-treated patients TCF Yip, GLH Wong, VWS Wong, YK Tse, GCY Lui, KLY Lam, HLY Chan Journal of hepatology 68 (1), 63-72, 2018 | 107 | 2018 |
| Can we use old NAFLD data under the new MASLD definition? SJ Song, JCT Lai, GLH Wong, VWS Wong, TCF Yip Journal of hepatology 80 (2), e54-e56, 2024 | 100 | 2024 |
| Long‐term safety of oral nucleos (t) ide analogs for patients with chronic hepatitis B: a cohort study of 53,500 subjects GLH Wong, YK Tse, VWS Wong, TCF Yip, KKF Tsoi, HLY Chan Hepatology 62 (3), 684-693, 2015 | 100 | 2015 |
| Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease S Shili‐Masmoudi, GLH Wong, JB Hiriart, K Liu, F Chermak, SST Shu, ... Liver International 40 (3), 581-589, 2020 | 95 | 2020 |
| Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B GLH Wong, HLY Chan, YK Tse, TCF Yip, KLY Lam, GCY Lui, VWS Wong Journal of hepatology 69 (4), 793-802, 2018 | 93 | 2018 |
| Prognostic value of controlled attenuation parameter by transient elastography K Liu, VWS Wong, K Lau, S Du Liu, YK Tse, TCF Yip, R Kwok, AYW Chan, ... Official journal of the American College of Gastroenterology| ACG 112 (12 …, 2017 | 84 | 2017 |
| Impact of the use of oral antiviral agents on the risk of hospitalization in community coronavirus disease 2019 patients (COVID-19) TCF Yip, GCY Lui, MSM Lai, VWS Wong, YK Tse, BHM Ma, E Hui, ... Clinical infectious diseases 76 (3), e26-e33, 2023 | 79 | 2023 |
| Asian perspective on NAFLD-associated HCC TCF Yip, HW Lee, WK Chan, GLH Wong, VWS Wong Journal of hepatology 76 (3), 726-734, 2022 | 76 | 2022 |
| Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment GLH Wong, HLY Chan, YK Tse, TCF Yip, KLY Lam, GCY Lui, CC Szeto, ... Alimentary Pharmacology & Therapeutics 48 (9), 984-992, 2018 | 68 | 2018 |
| Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B TCF Yip, GLH Wong, VWS Wong, YK Tse, LY Liang, VWK Hui, HW Lee, ... Journal of Hepatology 72 (5), 847-854, 2020 | 67 | 2020 |
| An aging population of chronic hepatitis B with increasing comorbidities: a territory‐wide study from 2000 to 2017 GLH Wong, VWS Wong, BWY Yuen, YK Tse, HWS Luk, TCF Yip, VWK Hui, ... Hepatology 71 (2), 444-455, 2020 | 67 | 2020 |
Grace lai hung WongThe Chinese University of Hong KongVerified email at cuhk.edu.hk
